本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

1.11
-0.0050-0.45%
盘后1.110.00000.00%17:41 EDT
成交量:13.39万
成交额:14.74万
市值:1,426.69万
市盈率:-1.02
高:1.13
开:1.13
低:1.07
收:1.12
数据加载中...
2019/03/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/01/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/10/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]